How to Evaluate Peptide Purity: HPLC, Mass Spec, and CoA Interpretation

Purity is the single most important quality attribute for any peptide product. A peptide labeled as 98% pure means something very specific — and understanding what that number includes, what it excludes, and how it was measured separates informed users from those relying on vendor claims at face value.

Why purity matters

An impure peptide contains unwanted compounds in addition to the intended sequence. These impurities fall into several categories:

Deletion sequences. During solid-phase peptide synthesis, each amino acid coupling step has less than 100% efficiency. If a coupling fails, the growing chain continues without that amino acid, producing a "deletion peptide" that is one residue shorter. A 15-amino-acid peptide (like BPC-157) synthesized with 99% coupling efficiency per step still yields approximately 14% deletion sequences. These deletion peptides have altered or absent biological activity.

Truncated sequences. Premature chain termination produces shorter peptide fragments. These may retain partial activity or no activity.

Oxidized variants. Methionine, cysteine, and tryptophan residues can oxidize during synthesis or storage. Oxidized peptides often retain similar mass but have reduced receptor binding.

Racemized residues. Harsh coupling conditions can convert L-amino acids to D-amino acids at certain positions. The resulting peptide has the correct sequence but incorrect stereochemistry at one or more positions, which can dramatically alter biological activity.

Residual solvents and reagents. Synthesis chemicals (TFA, DMF, piperidine) and cleavage reagents must be thoroughly removed. Residual TFA in particular can affect both biological activity and tolerability.

HPLC: the primary purity measurement

High-Performance Liquid Chromatography (HPLC) is the standard method for assessing peptide purity. Understanding how it works helps you interpret the results.

How it works. The peptide sample is dissolved and passed through a column packed with a stationary phase (typically C18-modified silica particles). Different molecular species interact differently with the column material, causing them to exit the column (elute) at different times. A UV detector measures absorbance at 214-220 nm (wavelengths where peptide bonds absorb) as each component elutes.

Reading the chromatogram. The result is a graph with retention time on the x-axis and UV absorbance on the y-axis. The target peptide appears as a large peak at a characteristic retention time. Impurities appear as smaller peaks at other times. Purity is calculated as:

Purity = (area of target peak / total area of all peaks) x 100%

What 98% purity means. The target peptide peak accounts for 98% of the total UV-absorbing material. The remaining 2% consists of deletion sequences, truncated peptides, oxidized variants, and other synthesis-related impurities.

HPLC limitations. Standard reversed-phase HPLC does not detect:

• Compounds that do not absorb UV at the detection wavelength (some salts, buffers)
• Co-eluting impurities (compounds that exit the column at the same time as the target peptide, hiding under the main peak)
• Water content, residual solvents, or counter-ion content (these require separate tests)

Mass spectrometry: identity confirmation

Mass spectrometry (MS) confirms that the main HPLC peak is actually the intended peptide by measuring its molecular mass.

How it works. The peptide is ionized (typically by electrospray ionization, ESI) and the mass-to-charge ratio of the resulting ions is measured. The observed molecular mass is compared to the theoretical mass calculated from the amino acid sequence.

What to look for on a CoA. The mass spec result should report:

• Observed mass: The measured molecular weight
• Expected (theoretical) mass: The calculated mass based on the sequence
• Mass accuracy: The difference between observed and expected, typically reported in Daltons or parts per million (ppm). An acceptable deviation is less than 0.1% or less than 1 Da for most peptides.

What mass spec confirms and what it does not. A matching molecular mass confirms the peptide has the correct amino acid composition and sequence length. It does not confirm:

• Correct amino acid order (isomers with the same composition have identical mass)
• Correct stereochemistry (L vs. D amino acids have identical mass)
• Purity percentage (that is HPLC's job)

For definitive sequence confirmation, tandem mass spectrometry (MS/MS) is required, where the peptide is fragmented and the fragment pattern reveals the amino acid order. This is not routinely included on standard CoAs.

Reading a certificate of analysis

A credible Certificate of Analysis (CoA) should contain, at minimum:

Essential information:

• Product name and sequence
• Lot/batch number
• HPLC purity (with method description: column type, gradient, detection wavelength)
• Mass spectrometry result (observed vs. expected mass)
• Physical appearance description
• Net peptide content (actual peptide weight vs. total powder weight, which includes counter-ions and moisture)

Additional quality indicators:

• Amino acid analysis (AAA) — confirms the ratio of amino acids in the sequence
• Residual solvent testing (TFA, acetonitrile, DMF levels)
• Endotoxin testing (LAL assay) — critical for injectable peptides
• Sterility testing — for products labeled as sterile
• Water content (Karl Fischer titration)

Red flags on CoAs

Generic or template CoAs. If every lot number produces identical analytical results, the CoA is likely fabricated. Real analytical data varies slightly between batches.

Missing lot numbers. A CoA without a lot number cannot be traced to a specific production batch. This makes verification impossible.

Purity claims without chromatograms. A number without the supporting HPLC trace is an assertion, not evidence. Reputable suppliers provide the actual chromatogram showing the peak profile.

Unrealistic purity claims. Claims of 99.9%+ purity for complex peptides (15+ amino acids) should be viewed skeptically. Achieving this level of purity consistently requires extensive purification that substantially increases cost.

No mass spec data. Without mass spectrometric confirmation, you have no evidence that the HPLC peak is the intended peptide rather than a different compound with similar chromatographic behavior.

Minimum quality standards

For research peptides intended for personal use, reasonable minimum standards include:

• Purity: 98% or higher by HPLC for most peptides. Shorter peptides (4-5 amino acids) can reasonably achieve 99%+. Longer, more complex peptides (30+ amino acids) at 95% may be acceptable.
• Identity: Mass spectrometry confirmation with less than 0.1% mass deviation.
• Endotoxin: Less than 5 EU/mg for injectable peptides. Less than 0.5 EU/mg for any peptide used near the eyes.
• Appearance: White to off-white lyophilized powder. Yellowed, discolored, or non-fluffy powder suggests degradation.

Third-party testing

The gold standard is third-party verification — sending a sample of the received product to an independent analytical laboratory for HPLC and MS testing. Services like Janoshik Analytical or university analytical chemistry departments can perform these tests. The cost (typically $50-150 per sample) provides genuine assurance that the product matches the vendor's claims.

This may seem excessive for a research compound, but it is the only way to independently verify what is in the vial. Vendor-provided CoAs are only as trustworthy as the vendor.